PortfoliosLab logo

Aurinia Pharmaceuticals Inc.

AUPH
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
CA05156V1022
CUSIP
05156V102

AUPHPrice Chart


Chart placeholderClick Calculate to get results
S&P 500

AUPHPerformance

The chart shows the growth of $10,000 invested in Aurinia Pharmaceuticals Inc. on Sep 4, 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $52,500 for a total return of roughly 425.00%. All prices are adjusted for splits and dividends.


AUPH (Aurinia Pharmaceuticals Inc.)
Benchmark (S&P 500)

AUPHReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M61.04%
6M54.87%
YTD51.84%
1Y40.37%
5Y59.16%
10Y26.58%

AUPHMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

AUPHSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aurinia Pharmaceuticals Inc. Sharpe ratio is 0.54. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


AUPH (Aurinia Pharmaceuticals Inc.)
Benchmark (S&P 500)

AUPHDividends


AUPH doesn't pay dividends

AUPHDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


AUPH (Aurinia Pharmaceuticals Inc.)
Benchmark (S&P 500)

AUPHWorst Drawdowns

The table below shows the maximum drawdowns of the Aurinia Pharmaceuticals Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aurinia Pharmaceuticals Inc. is 67.17%, recorded on Jan 19, 2016. It took 284 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-67.17%Mar 24, 2015208Jan 19, 2016284Mar 6, 2017492
-63.19%Mar 14, 2017652Oct 14, 201937Dec 5, 2019689
-53.4%Jan 3, 2020340May 10, 202188Sep 14, 2021428
-27.75%Sep 4, 201429Oct 14, 201411Oct 29, 201440
-17.5%Oct 30, 201414Nov 18, 20147Nov 28, 201421
-17.28%Dec 1, 201442Jan 30, 201518Feb 26, 201560
-9.86%Sep 15, 20212Sep 16, 2021
-8.49%Mar 3, 20156Mar 10, 20155Mar 17, 201511
-5.51%Dec 30, 20191Dec 30, 20192Jan 2, 20203
-3.03%Dec 18, 20191Dec 18, 20193Dec 23, 20194

AUPHVolatility Chart

Current Aurinia Pharmaceuticals Inc. volatility is 77.44%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


AUPH (Aurinia Pharmaceuticals Inc.)
Benchmark (S&P 500)

Portfolios with Aurinia Pharmaceuticals Inc.


Loading data...

More Tools for Aurinia Pharmaceuticals Inc.